Session » Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Date: Friday, November 6, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 0090

110 Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Rheumatology Disease Unit: Fracture, Neuropathy, and Pernicious Anemia Are Clues to Recognition

9:00AM-11:00AM: Abstract Number: 0079

Analysis of COVID-19 and Rheumatology Twitter Activity During the Pandemic Months

9:00AM-11:00AM: Abstract Number: 0098

CCL2 and CCR2 in Adult Onset Still’s Disease

9:00AM-11:00AM: Abstract Number: 0083

Chronic Nonbacterial Osteomyelitis Is Associated with HLA-B*27

9:00AM-11:00AM: Abstract Number: 0085

Classifications of Inflammatory Myopathies: Differentially Expressed Membrane-Bound Complement Regulators Allow Specific Patterns of Membrane Attack Complex Deposition

9:00AM-11:00AM: Abstract Number: 0084

Clinical Characteristics of Patients with Rheumatism of Juvenile Onset and Adult Onset in the BIOBADAGUAY Cohort

9:00AM-11:00AM: Abstract Number: 0100

Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 0092

Diagnosis of Behçet’s Disease: Comparison of Two Sets of Classification Criteria. Application in 111 Patients of a Well-defined Population

9:00AM-11:00AM: Abstract Number: 0082

Diffuse Sclerosing Osteomyelitis of the Jaw: An Underdiagnosed Disease in Maxillofacial Surgery Department

9:00AM-11:00AM: Abstract Number: 0097

Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with FMF?

9:00AM-11:00AM: Abstract Number: 0086

Geographic Distribution of Eosinophilic Fasciitis Cases in Massachusetts and Associated Environmental Triggers

9:00AM-11:00AM: Abstract Number: 0091

Helicobacter Pylori Infection, Autoimmune Disease and Paraproteinemia Influence the Presentation of a Cohort of 150 Pernicious Anemia Patients Diagnosed in a Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 0087

Hemophagocytic Syndrome. Clinical Characteristics and Prognostic Factors of a Series of 30 Clinical Cases

9:00AM-11:00AM: Abstract Number: 0099

Interleukin 6 Concentration in Synovial Fluid of Patients with Different Types of Arthritis

9:00AM-11:00AM: Abstract Number: 0077

Mimickers of Immunoglobulin G4-Related Disease

9:00AM-11:00AM: Abstract Number: 0081

Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome

9:00AM-11:00AM: Abstract Number: 0078

Retrospective Analysis of Clinical Characteristics and Classification Criteria Performance in a Single Center Cohort of 114 Patients Diagnosed with IgG4-Related Disease

9:00AM-11:00AM: Abstract Number: 0093

Review of Gastrointestinal Manifestations of Kohlmeier-Degos Disease

9:00AM-11:00AM: Abstract Number: 0095

Systematic Evaluation of Nine Monogenic Autoinflammatory Diseases Reveals Common and Disease-Specific Correlations with Allergy-Associated Features

9:00AM-11:00AM: Abstract Number: 0096

The Bicipital Stress Test: A Maneuver to More Accurately Diagnose Bicipital Tendinitis and Its Referred Pain Patterns

9:00AM-11:00AM: Abstract Number: 0089

The Risk Factors of Recurrence in Relapsing Polychondritis; A Study of 41 Cases

9:00AM-11:00AM: Abstract Number: 0088

The Spectrum of Hemophagocytic Lymphohistiocytosis: Autoimmunity vs. Malignancy

9:00AM-11:00AM: Abstract Number: 0080

Understanding Ankylosing Spondylitis –

9:00AM-11:00AM: Abstract Number: 0094

Validation Study of Proposed Diagnostic Criteria for Sympathetic Joint Effusion

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].